Chagas Clinical Research Platform
Founded: 2009, Uberaba, Brazil
460 members, from over 150 institutions and 24 countries
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it will identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
´Enabling discussions among researchers is an important tool for the improvement of efficiency, diagnosis and treatment.´Concepción Zúñiga Valeriano, Medical Doctor, Head of Chagas, Honduras